Fish & Richardson Named One of 24 Most Loved Law Firms by General Counsel; One of 10 Firms GCs Love for Pharma Work

Fish & Richardson has been named one of the 24 law firms that general counsel "love the most" and one of 10 firms GCs "love for pharma work" according to BTI Consulting Group's BTI Power Rankings: The Law Firms with the Best Client Relationships. The firms on the 2016 BTI Clientopia® 24 list have "honed their ability to serve clients so well that their relationships with general counsels have entered a sort of utopian existence where they earn glowing recommendations from clients and consistently win work." As one of the 10 strongest pharma firms in the country, Fish excels at "a special type of attentiveness" that helps these firms "earn the majority of their clients' work in the field."

In-house counsel consider these 24 law firms as both their leading primary provider and the first firms they recommend to other legal decision makers. A typical company relies on 42 law firms for their legal needs, but only two firms on average are considered "primary."

"Clients will invest in the law firms that invest in them," said BTI President Michael Rynowecer. "The way they measure that is client service and the components of client service, the law firm that really makes your clients' life easier."

The BTI rankings analyze the strength of client relationships based solely on objective feedback from the highest-ranking legal decision makers and GCs at the largest companies. According to the report, top legal decision makers are clear, articulate, and decisive when defining what client service means to them. Understanding the client's business and unique needs comes in at the top of the list. The report notes that clients want law firms to place legal advice into a business context in order to help manage business risk.

"It is an honor and a privilege to be selected for both of these lists," said Jonathan Singer, who leads Fish's Life Sciences Litigation Group. "We work hard to earn our clients' trust, to understand their businesses and risks, and to provide creative, cost-effective solutions to help them succeed. Whether it's protecting a valuable patent portfolio, obtaining a successful result in a post-grant proceeding, solving a regulatory issue, or winning in court, we bring the highest level of technical, scientific, and legal acumen to bear for our clients. We are a team and we win when our clients win."

Fish's Life Sciences Litigation Group was recently heralded for a major victory for client Gilead on June 6, 2016 when the firm got a $200 million jury verdict voided after proving Merck forfeited its right to assert its Hepatitis C drug patents against Gilead because of "unclean hands."

In May 2016, Fish was named one of the best law firms in the country for developing and delivering alternative fee arrangements (AFAs) in BTI Consulting Group's annual BTI State of Alternative Fee Arrangements 2016. Fish was one of only 22 firms - and the only IP law firm on the list - that corporate counsel find are the best at making AFAs a successful cost control tool with improved client focus, predictability in budgets, a more streamlined approach to the work, and double-digit savings.